The ATLAS™ screening assay reveals distinct CD4+ and CD8+ SARS-CoV-2 antigen response profiles which have implications to Omicron cellular immunity
J. J. Foti, K. Lema, J. Strickland, E. Tjon, A. Li, A. Rivera, C. Cabral, L. Cormier, L. Dowal, S. Rao, V. Vemulapalli, J. B. Flechtner
The paper uses the ATLAS assay to identify CD4+ and CD8+ T cell antigen responses to SARS-CoV-2 variants, revealing common epitopes and predicting Omicron spike mutation impacts.
bioRxiv · May 17, 2022 · PreprintImmunology